Rhelixa

Rhelixa is a biotech company in Tokyo, Japan, founded in 2015. It has 2 recorded funding rounds, most recently a Series B in August 2024.

Decoding Life, Creating Future.

Headquarters
Tokyo
Employees
11–50
Founded
2015
Business Model
B2B
Last Round
Series BAug 2024
Rounds
2

Indexed holds 2 funding rounds and 2 investors for this company. The full record is or through the API.

About

Rhelixa is a Tokyo-based biotechnology company and leading provider of epigenomic analysis services, applying proprietary technologies to analyze genomic, epigenomic, transcriptomic, and metagenomic data for life science research and development. Founded in 2015, the company partners with pharmaceutical, food, and healthcare companies to dramatically improve the efficiency and accuracy of R&D through scientific consulting and bioinformatics services. Its tagline reflects its mission to decode biological information to advance personalized health, drug development, and longevity research.

Summary

It lists 11–50 employees. Its most recent funding was a Series B round in Aug 2024. Investors include Global Brain and Kirin Health Innovation Fund.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Series BSeries BAug 2024

Sign up to see all 2 events

Funding: Venture Round through Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Rhelixa on Indexed.vc
<a href="https://indexed.vc/companies/rhelixa"><img src="https://indexed.vc/api/badge/company/rhelixa" alt="Rhelixa on Indexed.vc" width="260" height="76" /></a>